Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial

Stefanie Hiltbrunner, Christian Britschgi, Petra Schuberth, Lorenz Bankel, Thi Dan Linh Nguyen‐Kim, P. Gulati, Walter Weder, Isabelle Opitz, Olivia Lauk, Claudio Caviezel, Hans Bachmann, Annett Tabor, Petra Schröder, Alexander Knuth, Christian Münz, Rolf A. Stahel, Onur Boyman, Christoph Renner, Ulf Petrausch, Alessandra Curioni‐Fontecedro